Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazocin for ESBL-producing bacteria control
NCT00488189Phase 4Completed
- Sponsor
- Pfizer
- Start
- May 2007
- Primary completion
- Feb 2008
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin + tazobactam in bacterial infection, sponsored by Pfizer. Started May 2007; status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00488189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488189.